A COMPARISON OF A PLASMINOGEN-ACTIVATOR INHIBITOR-1 FUNCTIONAL ASSAY BASED IN THE USE OF UROKINASE WITH THE TRADITIONAL TISSUE-PLASMINOGEN ACTIVATOR BASED ASSAYS SYSTEM

被引：0
|
作者：
WOODHAMS, BJ
DUNCAN, A
HUTTON, RA
DEMOERLOOSE, P
机构：
[1] DADE AG,DUDINGEN,SWITZERLAND
[2] EMORY UNIV,DEPT PATHOL,ATLANTA,GA 30322
[3] ROYAL FREE HOSP,CTR HAEMOPHILIA,LONDON,ENGLAND
[4] GENEVA CANTONAL HOSP,GENEVA,SWITZERLAND
来源：
THROMBOSIS AND HAEMOSTASIS | 1995年 / 73卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1143 / 1143
页数：1
相关论文
共 50 条
  • [1] ON THE REVERSIBLE INTERACTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND WITH UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    LIJNEN, HR
    VANHOEF, B
    COLLEN, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (07) : 4041 - 4044
  • [2] PLASMINOGEN-ACTIVATOR INHIBITOR-1(PAI-1) AND TISSUE-PLASMINOGEN ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR-1(TPA-PAI-1) IN IDDM - PROFILE BY COMPLICATIONS
    SUMINSKI, R
    DASILVA, S
    SMITH, M
    ERBEY, J
    [J]. DIABETES, 1994, 43 : A197 - A197
  • [3] NEUTRALIZATION BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 OF MUTANTS OF TISSUE PLASMINOGEN-ACTIVATOR
    BERGUM, PW
    ERICKSON, LA
    [J]. ENZYME, 1988, 40 (2-3) : 122 - 129
  • [4] GENE INACTIVATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE
    CARMELIET, P
    SCHOONJANS, L
    STASSEN, JM
    KIECKENS, L
    VANNUFFELEN, A
    DEMOL, M
    COLLEN, D
    MULLIGAN, R
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 764 - 764
  • [5] TISSUE-PLASMINOGEN ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 DETECTED IN BLOOD AFTER CATARACT-SURGERY
    YAMADA, R
    KOMATSU, A
    TANE, S
    ISHII, A
    YAMADA, S
    [J]. JAPANESE JOURNAL OF OPHTHALMOLOGY, 1994, 38 (03) : 292 - 297
  • [6] KINETIC-ANALYSIS OF THE INTERACTIONS BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND BOTH UROKINASE AND TISSUE PLASMINOGEN-ACTIVATOR
    HEKMAN, CM
    LOSKUTOFF, DJ
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1988, 262 (01) : 199 - 210
  • [7] TGF-BETA INCREASES BOTH UROKINASE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    IWASA, M
    HASHIMOTO, K
    MATSUMOTO, K
    HIGASHIYAMA, M
    HASHIRO, M
    UEDA, K
    KIM, K
    NISHIDA, Y
    TAGO, H
    YOSHIKAWA, K
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (03) : 451 - 451
  • [8] TGF-BETA INCREASES BOTH UROKINASE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    IWASA, M
    HASHIMOTO, K
    MATSUMOTO, K
    HIGASHIYAMA, M
    HASHIRO, M
    UEDA, K
    KIM, K
    NISHIDA, Y
    TAGO, H
    YOSHIKAWA, K
    [J]. CLINICAL RESEARCH, 1989, 37 (02): : A635 - A635
  • [9] BIOLOGICAL EFFECTS OF DISRUPTION OF THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENES IN MICE
    CARMELIET, P
    BOUCHE, A
    DECLERCQ, C
    JANSSEN, S
    POLLEFEYT, S
    WYNS, S
    MULLIGAN, RC
    COLLEN, D
    [J]. ATHEROSCLEROSIS III: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH: THE THIRD SARATOGA INTERNATIONAL CONFERENCE ON ATHEROSCLEROSIS IN NEKOMA, 1995, 748 : 367 - 382
  • [10] BIOLOGICAL EFFECTS OF INACTIVATION OF THE GENES FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE
    CARMELIET, P
    SCHOONJANS, L
    KIECKENS, L
    STASSEN, JM
    BRONSON, R
    COLLEN, D
    MULLIGAN, R
    [J]. FIBRINOLYSIS, 1993, 7 : 27 - 28
12345